Re: Gillian Vandekerkhove, Werner J. Struss, Matti Annala, et al. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer. Eur Urol 2019;75:667

Re: Gillian Vandekerkhove, Werner J. Struss, Matti Annala, et al. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer. Eur Urol 2019;75:667–75

Published:2019-09 Issue:3 Volume:76 Page:e69-e72
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Montironi Rodolfo,Cheng Liang,Scarpelli Marina,Cimadamore Alessia,Montorsi Francesco,Lopez-Beltran Antonio

Publisher

Elsevier BV

Subject

Urology

Reference6 articles.

1. Circulating tumor DNA abundance and potential utility in de novo metastatic prostate cancer;Vandekerkhove;Eur Urol,2019

2. Cimadamore A, Scarpelli M, Santoni M, et al. Genitourinary tumors: update on molecular biomarkers for diagnosis, prognosis and prediction of response to therapy. Curr Drug Metab. 2019 Feb 25. [Epub ahead of print]. https://doi.org/10.2174/1389200220666190225124352

3. Cimadamore A, Gasparrini S, Massari F, et al. Emerging molecular technologies in renal cell carcinoma: liquid biopsy. Cancers (Basel). 2019 Feb 7;11(2). pii: E196.https://doi.org/10.3390/cancers11020196.

4. Plasma cell-free DNA concentration and outcomes from taxane therapy in metastatic castration-resistant prostate cancer from two phase III trials (FIRSTANA and PROSELICA);Mehra;Eur Urol,2018

5. in advanced prostate cancer: a biomarker revolution under way?;van Soest;Eur Urol,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA repair deficiency as circulating biomarker in prostate cancer;Frontiers in Oncology;2023-01-30

2. B2B: Prostate Cancer;Proceedings from the SIU B2B Uro-Oncology: GU Cancers Triad Virtual Meeting May 21–22, 2021;2021-07-16

3. Circulating Tumor DNA Testing for Homology Recombination Repair Genes in Prostate Cancer: From the Lab to the Clinic;International Journal of Molecular Sciences;2021-05-24

4. Circulating Tumour DNA as a Biomarker Source in Metastatic Prostate Cancer;Société Internationale d’Urologie Journal;2020-10-13

5. Classification of Molecular Biomarkers;Société Internationale d’Urologie Journal;2020-10-13